Skip to main
ISRG
ISRG logo

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 27%
Buy 53%
Hold 13%
Sell 0%
Strong Sell 7%

Bulls say

Intuitive Surgical has demonstrated robust growth with a 14% increase in Ion utilization and a 35% surge in SP utilization, reflecting strong demand and a growing installed base. The company's Da Vinci system utilization has improved by approximately 2% year-over-year, showcasing the benefits of the new D5 system and strong procedure growth despite typical seasonal fluctuations. Additionally, Intuitive Surgical has raised its gross margin guidance to 67-67.5%, driven by higher system placements and an improved tariff outlook, which indicates a positive trajectory for the company's financial performance.

Bears say

Intuitive Surgical's revenue from services fell slightly short of expectations at $396 million, indicating potential challenges in sustaining growth amid macroeconomic uncertainties affecting hospital capital budgets and robotic system purchases. The company continues to experience market resistance towards robotic surgical approaches, particularly in newer markets, alongside a prolonged rollout of next-generation systems and pressures on procedure volumes, particularly in bariatric surgery. Furthermore, external factors such as tariffs on imports from Mexico and the impact of third-party instrument reprocessing on consumable average selling prices contribute to an overall negative outlook for Intuitive Surgical's stock performance.

Intuitive Surgical (ISRG) has been analyzed by 15 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 53% recommend Buy, 13% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 15 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $595.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $595.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.